Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a …
Y Yong, X Zhao, H Li, W Wei, Y Zhang… - Chinese medical …, 2007 - journals.lww.com
Background The primary objectives of the treatment for the lower urinary tract symptoms
(LUTS) associated with benign prostatic hyperplasia (BPH) are to produce rapid, sustained …
(LUTS) associated with benign prostatic hyperplasia (BPH) are to produce rapid, sustained …
Medical and surgical treatment modalities for lower urinary tract symptoms in the male patient secondary to benign prostatic hyperplasia: a review
MR Macey, MC Raynor - Seminars in Interventional Radiology, 2016 - thieme-connect.com
Benign prostatic hyperplasia (BPH) with lower urinary tract symptoms (LUTS) is one of the
most common ailments affecting aging men. Symptoms typically associated with BPH …
most common ailments affecting aging men. Symptoms typically associated with BPH …
Double-blind placebo controlled study of α-adrenergic receptor antagonists (doxazosin) for treatment of voiding dysfunction in the pediatric population
SA Kramer, SR Rathbun, D Elkins, RJ Karnes… - The Journal of …, 2005 - Elsevier
PURPOSE:: We sought to determine whether the α-adrenergic antagonist doxazosin could
be used as primary therapy in children with voiding dysfunction. MATERIALS AND …
be used as primary therapy in children with voiding dysfunction. MATERIALS AND …
Acute urinary retention rates in the general male population and in adult men with lower urinary tract symptoms participating in pharmacotherapy trials: a literature …
M Oelke, MJ Speakman, F Desgrandchamps… - Urology, 2015 - Elsevier
Despite proven efficacy, antimuscarinics are not frequently used for treating lower urinary
tract symptoms in adult men, due to the perception of an increased risk of acute urinary …
tract symptoms in adult men, due to the perception of an increased risk of acute urinary …
Safety and efficacy of tolterodine extended release in men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia
K Höfner, M Burkart, G Jacob, U Jonas - World journal of urology, 2007 - Springer
Patients with presumed non-obstructive BPH (Q max≥ 15 ml/s) treated with tolterodine ER 4
mg/day for OAB symptoms, alone or added to unsuccessful alpha-blocker treatment of≥ 6 …
mg/day for OAB symptoms, alone or added to unsuccessful alpha-blocker treatment of≥ 6 …
Anticholinergic drugs in patients with bladder outlet obstruction and lower urinary tract symptoms: a systematic review
OBJECTIVES: To review the available evidence concerning the use of anticholinergic drugs,
alone or in combination with α-blockers, in patients with lower urinary tract symptoms (LUTS) …
alone or in combination with α-blockers, in patients with lower urinary tract symptoms (LUTS) …
Hiperplasia prostática benigna y síntomas del tracto urinario inferior. Revisión de las evidencias actuales
VM Carrero-López, JM Cózar-Olmo… - Actas Urológicas …, 2016 - Elsevier
Contexto El tratamiento de la hiperplasia benigna de próstata (HBP) está cambiando debido
a un mayor conocimiento de la enfermedad y al desarrollo del concepto funcional de los …
a un mayor conocimiento de la enfermedad y al desarrollo del concepto funcional de los …
Tamsulosin combined with solifenacin versus tamsulosin monotherapy for male lower urinary tract symptoms: a meta-analysis
M Gong, W Dong, G Huang, Z Gong… - … medical research and …, 2015 - Taylor & Francis
Objective: To evaluate the efficacy and safety of tamsulosin and solifenacin combination
therapy compared with tamsulosin monotherapy for male lower urinary tract symptoms …
therapy compared with tamsulosin monotherapy for male lower urinary tract symptoms …
Randomized controlled trial to treat benign prostatic hyperplasia with overactive bladder using an alpha‐blocker combined with anticholinergics
O Nishizawa, O Yamaguchi, M Takeda… - LUTS: Lower Urinary …, 2011 - Wiley Online Library
Objectives: TAABO was a randomized, controlled trial to evaluate the efficacy and safety of
combination therapy of tamsulosin (TAM) with propiverine (PROP) in men with both benign …
combination therapy of tamsulosin (TAM) with propiverine (PROP) in men with both benign …
A comparison of the frequencies of medical therapies for overactive bladder in men and women: analysis of more than 7.2 million aging patients
BT Helfand, RM Evans, KT McVary - European urology, 2010 - Elsevier
BACKGROUND: The study of overactive bladder (OAB) symptoms has historically focused
on women. However, it is now evident that men, including those with benign prostatic …
on women. However, it is now evident that men, including those with benign prostatic …